MoneyWorks4Me

Alembic Pharmaceuticals informs about updates

22 Mar 2025 Evaluate
Alembic Pharmaceuticals has informed that the Company has successfully completed the United States Food and Drug Administration (USFDA) inspection for its API-III Facility located at Karakhadi. This was a scheduled GMP inspection and was successfully completed without any Form 483 observation. The inspection was conducted from 17th March, 2025 to 21st March, 2025.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..